Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 2d agoRegular26.10.23 02:15SCHEDULE 13GOwnership#●●●
CITY THERAPEUTICS, INC.
Invus Public Equities, L.P. and affiliated entities have filed a Schedule 13G regarding their ownership of City Therapeutics, Inc. shares. Multiple investment entities represented by Raymond Debbane have jointly reported their stake in the company.…more
$20.60-1.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 06:384Ownership
CITY THERAPEUTICS, INC.
Insiders and major shareholders of CITY THERAPEUTICS, INC., including ARCH Venture Fund XII, L.P. and related parties, have filed a Form 4 report regarding changes in their beneficial ownership. This filing reflects updates to the stock holdings of key management and investors, which shareholders should monitor for potential implications.…more
$20.60-1.06%vs prev closeView filingShare - 5d agoAfter-hours26.10.20 06:374Ownership
CITY THERAPEUTICS, INC.
Insider Robert Nelsen filed a Form 4 report regarding his beneficial ownership of CITY THERAPEUTICS, INC. securities as of October 15, 2026. This filing serves as an official disclosure of changes in insider holdings.…more
$20.60-1.06%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoAfter-hours26.10.20 05:01Bullish#●●●#●●●
City Therapeutics Closes $230 Million Upsized IPO
Clinical-stage biotech company City Therapeutics has completed its upsized initial public offering, raising approximately $230 million in gross proceeds. The funds will support the development of the company's RNA interference therapeutic pipeline.…more
$20.60-1.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.16Regular26.10.16 22:50
●●●●●●●● ●●●●● ●●●●●●
The trading halt for the newly listed IPO security has been lifted, allowing market participants to resume trading. Investors should monitor the current quotes and market activity for the stock.…more
$20.60-1.06%vs prev closeShareBenzinga - 10.16Overnight26.10.16 15:32
●●●●●●●● ●●●●● ●●●●●●
City Therapeutics has finalized its initial public offering of 11,111,111 shares at $18.00 per share, aiming to raise approximately $200 million. This capital raise through a public offering will result in share dilution for existing shareholders.…more
$20.60-1.06%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report